MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday. The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 316,184 shares changing hands. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a current ratio of 2.69, a quick ratio of 3.10 and a debt-to-equity ratio of 1.19. The firm’s fifty day moving average price is C$0.07 and its 200 day moving average price is C$0.07. The stock has a market capitalization of C$27.77 million, a price-to-earnings ratio of -6.50 and a beta of -0.44.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
See Also
- Five stocks we like better than MediPharm Labs
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
